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Abstract
Background: The genus Lactobacillus belongs to a large heterogeneous group of low G + C Gram-positive anaerobic
bacteria, which are frequently used as probiotics. The health-beneficial effects, in particular the immunomodulation
effect, of probiotics depend on the strain and dose used. Strain variations may be related to diversity of the cell surface
architecture of bacteria and the ability to express specific antigens or secrete compounds. The use of Lactobacillus as
probiotic requires a comprehensive understanding of its effect on host immune system. To evaluate the potential
immunoreactive properties of proteins isolated from four Lactobacillus strains: L. johnsonii 142 and L. johnsonii 151, L.
rhamnosus LOCK 0900 and L. casei LOCK 0919, the polyclonal sera obtained from mouse and human have been tested
as well as with sera from rabbits immunized with whole lactobacilli cells.
Results: The reactivity of isolated proteins detected by SDS-PAGE and Western blotting was heterogeneous and varied
between different serum samples. The proteins with the highest immunoreactivity were isolated, purified and sequenced,
in particular the fractions were identified as phosphoglycerate kinase (L. johnsonii 142), glyceraldehyde 3-
phosphate dehydrogenase (L. johnosnii 142, L. rhamnosus LOCK 0900), hypothetic protein JDM1_1307 (L.
johnsonii 151) and fructose/tagatose-bisphosphate-aldolase (L. casei LOCK 0919).
Conclusion: The different prevalence of reactions against tested antigens in rabbit, mouse and human sera
may indicate significant differences in immune system and commensal cross-talk in these groups. The
identification of immunoreactive lactobacilli proteins opens the possibility to use them as an antigens for
development of vaccines.
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Background
Lactobacillus are nonpathogenic Gram-positive bacteria
that form part of the normal intestinal microbiome in
humans and animals. They are a large group of bacteria
growing under microaerophilic conditions for optimal
growth temperature in the range of 30–40 °C and
pH 5.5–6.2 typically. The Lactobacillus species are com-
monly used to manufacture fermented milk products
and some of them are considered probiotics on account
of their health benefits [1–5]. Moreover, they are “gener-
ally regarded as safe” according to The American Food
and Drug Administration due to their long history of
safe use in fermented foods and their presence in the
normal intestinal and urogenital microbiome of humans.
The mechanisms underlying probiotic effect are gener-
ally attributed to the interaction of probiotics with other
microorganisms (bacteria-bacteria cross-talk) or with
host cells (bacteria-host cross-talk). The interactions de-
pend on the viability of probiotic cells, since it is exerted
by competitive exclusion, direct inhibition of certain
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microorganisms involving production of antimicrobial
molecules or increased growth of healthy components of
the microbiota, while the interaction with the host is
based on the capacity of host cells to recognize specific
bacterial components or products, giving rise to re-
sponse that commonly involve the immune system [6].
The lactic acid bacteria influence has been described
as enhancement of non-specific immunity as well as ad-
juvant and immunoregulatory effects in adaptive im-
mune responses. However, the bacterial components
responsible for these effects are often left unidentified.
The Lactobacillus bacteria show great diversity in the
cell surface architecture which may influence to the
physicochemical properties of the bacterial cell and
strain specific properties. The cell envelope of lactoba-
cilli is composed of the bilayer lipid cell membrane with
embedded proteins anchored to the cell wall and cov-
ered by thick multilayered peptidoglycan together with
lipo- and teichoic acids, pili and polysaccharides sheet.
Polysaccharides can either attach to the cell surface like
an outer capsule and often be covalently bound to N-
acetylmuramic acid of peptidoglycan or be loosely at-
tached with it or be secreted to the surrounding
environment.
The cell surface proteins are anchored to the cell wall
by various mechanisms or released into the surrounding
medium, where they reassociate with the cell wall
through electrostatic interactions [7]. Covalently an-
chored proteins can be divided into N- or C-terminally
anchored proteins, lipoproteins and LPXTG-anchored
proteins (or sortase-dependent proteins). N-terminally
anchored proteins are involved in extracellular transport,
signal transduction and protein turnover, while lipid-
anchored proteins are involved in adhesion, antibiotic
resistance, folding and translocation of proteins [8–10].
LPXTG-anchored proteins have been demonstrated to
be crucial for the interactions of pathogenic and non-
pathogenic bacteria with their hosts [11]. Some species
of lactobacilli produce an additional paracrystalline layer
of proteins called as S-layer. This is a two-dimensional
crystal layer consisting of 25–71 kDa molecular mass
proteins mainly and highly predicted overall pI value
(9.4–10.4), and represent 10–15 % of the total cell pro-
tein content [12–14]. The lattice symmetry of Lactoba-
cillus S-layer proteins is of oblique or hexagonal type
[15]. The most often proposed function for S-layer is
mainly reduction the ability of pathogens adhesion and
invasion or reduction theirs toxins activity [4, 5, 16–19].
Some other cell surface proteins were also shown to be
involved in adhesion to human intestinal cells and mu-
cins, stimulation of cytokine secretion and mediation of
co-aggregation of probiotic bacteria with pathogenic
bacteria [20]. Pili have been identified at the genome
level in some lactobacilli, however only in L. rhamnosus
GG polymeric structures and functionality have been
characterized [21]. The flagella have been recognized
only in twelve species of lactobacilli, and comprises
flagellin, protein which is suggested to activate of
signaling pathways and modulate of host immune
cells [22].
The other key molecules are extracellular proteins
which could regulate certain signaling pathways and cel-
lular responses, including secretion of different effector
molecules such chemokines, cytokines, antibacterial pep-
tides, mucus secretion, induction of changes in the sur-
face properties and modulation of the immune function
and the immune response of the host cells [23]. It is
known that Lactobacillus bacteria interact with epithelial
cells trough several mechanisms mediated by extracellu-
lar and cell-surface-associated proteins that bind to
mucus and intestinal cells [24]. Lactobacillus adhesion
to mucus involves mucus binding proteins (Mubs) which
in addition to the same domain organization typical for
cell surface proteins share a mucus binding domain [25].
The MucBPs (putative mucus binding proteins) have
been found among 13 different Lactobacillus strains
[26]. L. fermentum produced a 32 kDa surface-associated
protein (32-mMubp) that is suggested to mediate adhe-
sion to mucus [27], whereas studies with L. rhamnousus
GG have shown a mucus binding factor with a presumed
ancillary involvement in pilus-meditative mucosal adhe-
sion [28]. Recent studies of L. casei BL23 sortase have
shown that this sortase might be involved in adhesion of
this strain to Caco-2 and HT cells [29]. L. johnsonii has
been found to produce elongation factor Tu (EF-Tu)
which mediated the attachment to human intestinal
cells and mucins [20]. The issue of lactobacilli antigens
supporting probiotic action in probiotic bacteria has
been extensively reviewed by Lebeer et al. [30, 31], by
Kleerebezem et al. [10] and by Sengupta et al. [32],
however studies on the immunoreactivity of the lactobacilli
molecules are sparse. In our previous studies of two struc-
turally different exopolysaccharides isolated from L. johnso-
nii 142 and L. johnsonii 151 [33, 34] we have shown that
both antigens differed in their reactivity with human sera. It
appeared that physiological sera of healthy adult blood do-
nors contain antibodies reactive with studied exopolysac-
charides, at relatively high titers. Moreover, such antibodies
are also present in human umbilical cord blood sera.
The aim of this study was to identify immunoreactive
proteins of four Lactobacillus strains: L. johnsonii 142
and L. johnsonii 151, L. rhamnosus LOCK 0900 and L.
casei LOCK 0919. The proteins immunoreactivity with
13 sera (from mice, from human healthy adults, human
umbilical cord blood sera and from rabbits immunized
with cells) was detected by SDS-PAGE and Western
blotting. As a result, several major immunoreactive pro-
teins were identified.
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Results
The protein concentration in extracts of the studied
strains was significantly different and varied, ranging
from 3.1 to 18.7 mg/ mL. We observed that extraction
of protein with sodium dodecyl sulfate procedure was
no effective in case of L. rhamnosus LOCK900, probably
due to the presence of polysaccharide slime produced by
these bacteria. Thus the slime has been removed mech-
anically which allowed to increase the efficiency of the
protein extraction by 300 %. Samples were electropho-
resed and stained with Coomassie Brilliant Blue. The
representative results are shown in Fig. 1. It could be dem-
onstrated that proteins ranged in molecular mass from >
100 kDa to about 20 kDa. The profiles were quite variable,
emphasizing the heterogeneity in species, however it has
been shown to share several predominant bands.
For the analysis of immunoreactivity, protein samples
were transferred to a polyvinylidene difluoride mem-
brane for immunoblotting. This experiment resulted in a
detection of proteins reacting with analyzed sera and
several delineations were revealed. In case of L. johnsonii
142, there were five protein bands with the molecular
mass of about 90, 67, 50, 25 and 18 kDa reacting with
homologous sera (Fig. 2, s3, line 1), two immunoreactive
protein fractions reacting with sera against L. animalis
murinus 148 (ca. 67 and 43 kDa, Fig. 2, s2, line 1), six
major protein fractions reacting with sera against L.
johnsonii 151 (ca. 90, 67, 53, 43, 38 and 35 kDa, Fig. 2,
s4, line 1) and several proteins ca. 67, 43, 30 kDa react-
ing with sera against L. paracasei LOCK 0912 (Fig. 2, s1,
line 1). We detected a marked reaction of protein about
30 kDa with sera from mouse kept under specific-
pathogen-free conditions (SPF conditions, Fig. 2, s6, line
1) and with mouse kept under conventional conditions
(Fig. 2, s7, line 1), however there were no reactions with
sera obtained from germ free mouse (Fig. 2, s5, line 1).
The antibodies against protein 35 kDa were detected in
several human sera, namely s8-s10 and one umbilical
cord blood serum (s11), but the reaction was very weak.
In case of protein extract from L. johnsonii 151 we ob-
served several immunoreactive proteins, however hom-
ologous reactivity was blurred (Fig. 2, s4, line 2) and
enabling determination of the approximate molecular
mass. Strain 151 produced small proteins (ca 40 kDa)
which reacted with other rabbit sera (Fig. 2, s1-s3, line
2), and very weak with human sera (Fig. 2, s8-s13, line
2). We didn’t observe reactivity with sera from mice
(Fig. 2, s5-s7, line 2). Considering human origin species
L. casei LOCK 0919 we observed a broad reactivity of
protein with molecular mass of about 90 kDa, in par-
ticular, as the only one of the tested bacterial proteins
reacted clearly with human umbilical cord blood sera
(Fig. 2, s8-s10, line 4). Weak cross-reactivity with mouse
serum has been noticed for proteins of molecular mass
of 30 and 43 kDa isolated from LOCK 0900 (Fig. 2, s7,
line 4). Interestingly, six proteins of LOCK 0900 and
LOCK 0919 have been shown to cross-react with serum
against L. johnsonii 142 (Fig. 2, s3, lines 3–4).
To identify the most immunogenic/immunoreactive
proteins, electrophoretic preparation of isolated proteins
from four analyzed strains was made using Prep-Cell
Apparatus (491 model Bio-Rad) and re-analyzed in the
immunoblotting assays. The representative results were
shown on Figs. 3 and 4. Bands with molecular mass of
about 20 kDa (immunoreactive with serum against L.
johnsonii 142) and 38, 40, 42 kDa (reacting with rabbit,
human or mouse sera) isolated from L. johnsonii 142,
one spot of 45 kDa from L. johnsonii 151 (reacting with
rabbit sera against L. johnsonii 151 and human sera),
and two bands of 35 and 50 kDa from L. rhamnousus
LOCK 0900 and also two bands of 30 and 50 kDa iso-
lated from L. casei LOCK 0919 showing strong immuno-
reactivity features were cut from the gel and analyzed in
LC-MS/MS. Proteins were identified by comparative
analysis of peptides masses (NCBI, UniProt databases)
using MASCOT and statistical analysis. These proce-
dures failed to obtain and identify the most reactive pro-
tein (90 kDa) in extract of LOCK 0919. The results of
sequencing and most like homologies of isolated and
Fig. 1 SDS-PAGE profile with Coomassie Brilliant Blue staining of
proteins isolated from Lactobacillus strains: M – low molecular
mass marker, 1 – L. johnsonii 142, 2 – L. johnsonii 151, 3 – L. rhamnosus
LOCK 0900, 4 – L. casei LOCK 0919. These images were cut from the
same gel, merged and the appropriate scaling was used
Górska et al. BMC Microbiology  (2016) 16:17 Page 3 of 11
analyzed proteins with spectrometric method have been
summarized in Table 1. The highest protein sequence
coverage of L. johnsonii 142 we observed for spot with
molecular mass about 42 kDa. This protein has been
identified as the phosphoglycerate kinase (79 % protein
sequence coverage), whereas the protein 45 kDa of L.
johnsonii 151 strain has not been identified. However,
we noticed low sequence coverage (39 %) corresponded
to hypothetical protein JDM1_1307 from L. plantarum
JDM1. Other immunoreactive proteins of L. johnsonii
142 were identified as glyceraldehyde 3-phosphate, de-
hydrogenase 30S ribosomal protein S7 and surface anti-
gen NLP/P60 with 67, 60 and 48 % protein sequence
coverage, respectively. Spot with molecular mass of
35 kDa isolated from strain LOCK 0900 was identified
as glyceraldehyde 3-phospahte (60 %), however a slightly
lower sequence coverage (59 %) was obtained for fruc-
tose/tagatose-bisphosphate-aldolase (59 %). The 50 kDa
spot of LOCK 0900 was characterized by a low homology
with aminopeptidase C (31 %). Interestingly, the immuno-
reactive spot with molecular mass around 30 kDa isolated
from L. casei LOCK 0919 was identified as fructose/
tagatose-bisphosphate-aldolase (88 % protein sequence
coverage) while for the second analyzed protein
(50 kDa) lower score (42 %) for glucose-6-phosphate
isomerase was obtained.
Fig. 2 Immunoblotting of proteins isolated from analyzed strains: M – low molecular mass marker: 94, 67, 43, 30, 20.1, 14.4 kDa, line 1 – L. johnsonii
142, line 2 – L. johnsonii 151, line 3 – L. rhamnosus LOCK 0900, line 4 – L. casei LOCK 0919, with sera: s1– rabbit polyclonal serum against L. paracasei
LOCK 0912, s2 – rabbit polyclonal serum against L. animalis murinus 148, s3 – rabbit polyclonal serum against L. johnsonii 142, s4 – rabbit polyclonal
serum against L. johnsonii 151, s5 – serum from germ free mouse, s6 – serum from mouse living under pathogen free conditions, s7 – serum from
mouse living under conventional conditions, s8-s10 sera from human healthy adults, s11-s13 human umbilical cord blood sera. These images were cut
from the same gel, merged and the appropriate scaling was used
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Discussion
The unraveling of the molecular mechanisms underlying
the lactobacilli biological effects is an attractive field for
investigation. Among the different cellular molecules,
proteins might mediate certain interactions, since they
would be able to interact directly with host immune sys-
tem. To date, our knowledge of the identity of proteins
responsible for immunomodulatory effect is very limited,
although several studies have reported the interaction
between lactobacilli proteins and human cells, few have
been identified and characterized so far [35–37]. In our
studies we focused on identification of potentially immu-
noreactive/immunogenic proteins of four strains: two iso-
lated from mouse (L. johnsonii 142 and 151) and two
isolated from human (L. rhamnosus LOCK 0900 and L.
casei LOCK 0919) using electrophoretic, immunoblotting
and mass spectrometry method. The reactivity of isolated
proteins detected by SDS-PAGE and immunoblotting was
heterogeneous and varied between different serum sam-
ples. The different prevalence of reactions against tested
antigens in rabbit, mouse and human sera may indicate
significant differences in immune system and commensal
cross-talk in these group. The reason could be the way of
immunization, as rabbit vaccination differs from a native
intestinal stimulation of immunity, moreover rabbit im-
mune response differs markedly from that of mice and hu-
man organism. Lactobacilli as food-grade and potentially
probiotic organisms with therapeutically purposes should
be non-immunogenic reflected in an inability to evoke
antibody responses against themselves. However it has
been shown that some Lactobacilli and Bifidobacteria
strains can stimulate the production of secretory
Fig. 4 The selected immunoblots of separated proteins: A – immunoreactive protein of L. johnsonii 142 reacting with homologous serum
(s3), B – immunoreactive proteins of L. johnsonii 142 reacting with anti-L. paracasei LOCK 0912 (s1), C – immunoreactive protein of L. johnsonii 151 reacting
with anti-L. johnsonii 151 (s4), D – immunoreactive proteins of L. rhamnosus LOCK 0900 reacting with anti-L. paracasei LOCK0912 (s1), E – immunoreactive
proteins of L. rhamnosus LOCK 0900 reacting with human cord blood sera (s12), F – immunoreactive proteins L. casei LOCK 0919 reacting with mouse CV
sera (s6), G – immunoreactive proteins L. casei LOCK 0919 reacting with rabbit anti-L. paracasei LOCK 0912 (s1). These images were taken from different
blots, merged and the appropriate scaling was used
Fig. 3 The SDS-PAGE profile of a separated proteins isolated from Lactobacillus johnsonii 151 in the presence of low molecular mass marker – 94,
67, 43, 30, 20.1, 14.4 kDa by continuous-elution electrophoresis (Prep-Cell apparatus Model 491 Bio-Rad). Samples are electrophoresed through a
cylindrical gel. As molecules migrate through the gel matrix, they separate into bands. Individual bands migrate off the bottom of the gel where
they pass directly into the patented elution chamber for collection. The resulting liquid fractions (2 ml) were pooled (5 fractions), dried and analyzed
on SDS-PAGE. Gels were stained with Coomassie Brilliant Blue
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Table 1 Identification of immunoreactive proteins isolated from Lactobacillus strain
Strain number Estimated molecular mass
of isolated protein [kDa]
Homologous protein name Nominal molecular mass of
homologous proteins [kDa]
Origin of homologous protein Decription Homology [%]
L. johnsonii 142 20 30S ribosomal protein S7
(gi116495953 )




36,929 Lactobacillus rhamnosus HN001 It is involved in the glucose metabolism
and has oxidoreductase activity
67
40 surface antigen NLP/P60
(gi 199598074 )
40,947 Lactobacillus rhamnosus GG Human mucus binding proteinn 48
42 phosphoglycerate kinase
(gi 199597273 )
42,187 Lactobacillus rhamnosus HN001 It is involved in glycolysis. Transfers a
phosphate group from 1,3-
bisfosfoglicerynianu to ADP creating
3-phosphoglycerate and ATP.
79
L. johnsonii 151 45 Hypothetical protein
JDM1_1307 (gi
254556474 )






36,912 Lactobacillus casei ATCC 334 It is involved in the glucose metabolism





36,360 Lactobacillus rhamnosus LMS2-
1
It is involved in the metabolism of
carbohydrates. It also participates
in the binding of zinc ions, and











31,640 Lactobacillus casei ATCC 334 It is involved in the metabolism of
carbohydrates. It also participates
in the binding of zinc ions, and





49,292 Lactobacillus casei ATCC 334 Catalyze the reaction: transformation















antibodies such as IgA and IgG. Maassen et a. described
that orally administered individual Lactobacillus strains
are able to differentially affect IgG1 versus IgG2a antibody,
depending on bacteria growth phase [38]. Prangli et al.
found IgG antibodies against common lactobacilli cyto-
plasmic proteins GroEl, enolase, transcription factor EF-Ts
and EF-Tu in children with type 1 diabetes and coeliac
disease [39]. In our study we also indicate immunoreactive
proteins which are recognized by rabbit/mouse and hu-
man immune system and elicit an antibodies. The proteins
with the highest immunoreactivity were isolated, purified
and sequenced, in particular the fractions were identified
as phosphoglycerate kinase, 30S ribosomal protein, surface
antigen NLP/P60 (L. johnsonii 142), glyceraldehyde 3-
phosphate dehydrogenase (L. johnosnii 142, L. rhamnosus
LOCK 0900), hypothetic protein JDM1_1307 (L. johnosnii
151), fructose/tagatose-bisphosphate-aldolase (L. casei
LOCK 0919 and L. rhamnosus LOCK 0900) and glucose-
6-phosphate isomerase (L. casei LOCK 0919) and amino-
peptidase C (L. rhamnosus LOCK 0900). This protein are
well-known as cytosolic metabolic enzymes or translation
protein and not as a surface proteins. However, over the
past decade, it has become clear that many proteins have
one or more unique functions over-and-above the principal
biological action of the specific protein. This phenomenon
is now known as protein moonlighting. The mechanism of
how bacterial moonlighting proteins translocate to the cell
exterior has remained unknown. They can be released from
dead or damaged cells and then bind to neighboring cells,
or they can be secreted onto the cell surface by an as-yet-
undescribed mechanism [40]. Most of multifunctional pro-
teins described in literature are virulence factors of Gram-
positive pathogens. Homologs have been also identified ei-
ther cell-surface-associated and/or in extracellular space of
commensal bacteria including lactobacilli. Their number
and moonlighting functions have significantly increased
during the last five years. The identified immunoreactive
glycolytic enzymes glyceraldehyde-3-phosphate dehydro-
genase, phosphoglycerate kinase, glucose-6-phosphate
isomerase and 30S ribosomal protein are among the most
common of the commensal bacterial moonlighting proteins
[41]. Lactic acid bacteria display on the cell surface cyto-
solic proteins that recognize yeast mannan. The glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) is involved in
glucose metabolism, catalyzing the metabolism of glucose
to release carbon as an energy source, however the other
study shown that play important role in adhesion phenom-
ena, or as immunomodulatory factor and recognizes hu-
man A and B blood group antigens [42, 43]. Studies have
shown that commensal Lactobacillus crispatus and several
other species of the acidophilus group of Lactobacillus have
GAPDH as major constituents of their extracellular prote-
ome at neutral pHs and that they are easily released from
the cell surface into incubation buffer [44, 45]. The catalytic
site in the GAPDH protein was suggested to be involved in
the binding to colonic mucin since the binding was inhib-
ited by NAD [46]. Extracellular GAPDH of L. plantarum
also binds fibronectin [47]. GAPDH and phosphoglycerate
kinase were found to be secreted to culture media by L.
rhamnosus GG [48]. In our work we indicated that
GAPDH is at least one of immunogenic protein of Lactoba-
cillus johnsonii 142 and immunoreactive protein of L.
rhamnosus LOCK 0900 and suggested the importance in
cross-talk between bacteria and their host. Previously it was
shown that GAPDH of S. agalactiae is an immunomodula-
tory protein and that recombinant GAPDH activates T and
B cells [49]. The GAPDH of S. pneumoniae was reported to
be antigenic in humans as well as to elicit protective im-
mune responses in the mouse [50].
A part from immunogenic GAPDH, the main immuno-
reactive protein 42 kDa of L. johnsonii 142 was identified
as phosphoglycerate kinase (PGK). This enzyme catalyses
the reversible phosphoryl transfer between 1,3-bispho-
sphoglycerate and ADP to form 3-phosphoglycerate and
ATP, and plays a crucial role in the Embden-Meyerhof-
Parnas pathway of glycolysis and in gluconeogenesis. This
important role is reflected by the enzyme structure that
has been highly conserved throughout evolution [51]. It
has been shown that PGK isolated from L. delbrueckii
subsp. lactis NCC88 plays a crucial function in regenerat-
ing ATP, however in not allosteric enzyme suggesting that
is not one of the key enzymes of the energy metabolism
regulation of L. delbrueckii subsp. lactis [52]. In addition,
PGK has been recognized as protective antigen against
various serotype of Streptococcus agalactiae and the
hyperimmune sera against phosphoglycerate kinase pro-
tect neonatal animals from S. agalactiae infection [53].
We identified the most immunoreactive 30 kDa protein of
Lactobacillus paracasei LOCK 0919 (human origin) as
fructose/tagatose-1,6-bisphosphate-aldolase which is the
fourth enzyme in glycolysis and catalyses the reversible
cleavage of fructose-1, 6-bisphosphate into dihydroxyacet-
one phosphate and glyceraldehyde 3-phosphate. Aldolase
was found in mutanolysin extract of S. pneumoniae. Anti-
bodies against aldolase protected against respiratory chal-
lenge with S. pneumoniae [50]. This study demonstrates
for the first time that GAPDH, PGK fructose/tagatose-
bisphosphate-aldolase, 30S ribosomal protein, glucose-6-
phosphate isomerase and aminopeptidase C from Gram-
positive commensal strain not pathogen are able to induce
the immune response and elicited antibodies.
All studied nonimmune human sera, not only of adult
blood donors, but also from umbilical cord sera, contain
antibodies recognizing Lactobacillus casei LOCK 0919
derived main protein of 90 kDa. The presence of anti-
90 kDa protein antibodies in human sera is unclear and
our studies are initiated to solve the question of the bio-
logical role of such antibodies.
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Interestingly, in our previous study we have shown
that L. johnsonii 142 isolated from mouse with inflam-
matory bowel disease (IBD) produced polysaccharide
with different structure than L. johnsonii 151 isolated
from healthy mouse, also reflected in their immunoreac-
tivity [33, 34]. The strains varied also considerably in re-
activity of their protein. This could suggest the relation
of bacterial antigens synthesized by bacteria colonizing
the gut with ongoing inflammatory process, especially sur-
face antigens. The question arises whether resident strains
of IBD mice could start the regulation of several proteins
or production of surface antigens with specific motifs in
their structure, which are absent in antigens of bacteria
from the normal gut flora. This also may suggest that the
antigens of lactobacilli may have an effect on host re-
sponses related to the inflammatory process in IBD.
Comparison of the results showed that there was a
great diversity in the immunoreactive proteins amongst
the lactobacillus strains, however there were some simi-
larities and consistencies amongst strains both within
the species and across the species. In particular it may
be of relevance that the presence of GAPDH in mouse
and human origin strains were detected as one of the re-
active proteins with various sera. However, all identified
proteins are common immunogenic proteins that are
present in several microorganisms and could well con-
tribute to the known immunomodulatory effect of
lactobacilli.
Conclusions
During the last ten years, the number of applications de-
veloped or suggested for Lactobacillus has gradually in-
creased [54]. One of the fields currently studied is the
development of vaccine based on lactobacilli. It has been
already shown that Lactobacillus increase the immuno-
genicity of orally administrated vaccines such as rota-
virus [55], polio [56], cholera [57] or influenza [58].
Recently, extensively analyzed is the construction of S-
layer protein for use in immunization in man or animals
[59–61]. The identification in our study of immunoreac-
tive proteins opens the possibility to use them also as
carries of antigens or other medically important mole-
cules, possibly in combinations with immunostimulatory
or adhesive molecules.
Methods
Microorganisms and growth conditions
The strain of Lactobacillus johnsonii 151 was isolated
from the intestinal tract of healthy mice housed under
SPF conditions, whereas Lactobacillus johnsonii 142 was
isolated from the intestinal tract of mice with experi-
mentally induced inflammatory bowel disease. The spe-
cies identification was performed using either PCR with
primers for 16S–23S rRNA or rep-PCR using GTG5
primers [33, 34]. Lactobacillus rhamnosus LOCK 0900
(formerly Lactobacillus casei LOCK900 [62]; patent no.
209988) was isolated from feces of a healthy 26-year-old
woman, whereas Lactobacillus casei LOCK 0919
(formerly Lactobacillus paracasei LOCK919 [63]; patent
no. 209986), was originally isolated from a fecal sample
collected from healthy 5-year-old boy. Both strains were
obtained from the Pure Culture Collection of the Tech-
nical University, Lódz, Poland. The species of the Lacto-
bacillus genus were identified based on the sequences of
genomic markers, such as 16S rRNA, rpoA, and pheS
genes [64].
The strains were stored at −75 °C in MRS broth
(Difco) supplemented with 20 % glycerol, and were sub-
cultured twice in MRS broth (Biocorp) under anaerobic
conditions at 37 °C before use. The growth of the organ-
ism was carried out at 37 °C for 48 h.
Other lactobacilli strains: L. animalis murinus 148
(mouse origin) and L. casei LOCK0912 (human origin)
were used for the preparation of rabbit antisera and were
cultivated in the same conditions.
Protein isolation
Bacterial strains were cultured on MRS broth (Biocorp)
for 48 h at 37 °C and centrifuged (6000 g, 4 °C, 20 min)
than suspended directly in the buffer for electrophoresis
according to Heilmann et al. [65]. Briefly, the cell pellet
was resuspended in 1 volume of buffer: 0.5 M Tris-HCl
(pH = 6,8)/SDS (0,08 % w/v)/glycerol (20 % v/v)/1 mM
β-mercaptoethanol (v/v) and boiled for 5 min. After cen-
trifugation, proteins were precipitated from the resulting
supernatant using 3 volumes of cold 95 % ethanol
(POCh). After overnight incubation at 4 °C, the precipi-
tated proteins were centrifuged (12 000 rpm) and dis-
solved in water. Protein concentration was analyzed
using the Lowry’s method [66].
In experiments with Lactobacillus rhamnosus
LOCK900 which is characterized by high amount of
slime production [67], before protein isolation proced-
ure, the polysaccharide slime which was loosely attached
to bacterial cells was removed mechanically by several
centrifugation at 14 500 g.
SDS-PAGE and immunoblotting
Equal amounts of proteins samples (10 μg) were ana-
lyzed on SDS-PAGE using 5 to 12.5 % gels according to
Laemmli [68]. Electrophoretic separation were carried
out at 100 V, using Tris-Glycine-SDS as running buffer.
After electrophoresis, gels were stained with Coomassie
Brilliant Blue (Serva) or soaked in transfer buffer
(10 mM Tris-HCl, 150 mM glycine, 20 % methanol,
pH 8.3) for 30 min. and transferred to a polyvinylidene
difluoride membrane (Millipore) for immunoblotting
(for 1 h at 100 V). Then the membranes were blocked in
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phosphate buffered saline (PBS) containing 1 % of bo-
vine serum albumin (BSA, KPL) for 1 h. Afterwards, the
membranes were washed three times with PBS contain-
ing 0.25 % Tween 20 (Sigma-Aldrich), PBS-T (Institute
of Immunology and Experimental Therapy, PAN), and
incubated in a selected sera in 1 % BSA for 2 h at 37 °C.
We tested different dilutions of sera but the most effect-
ive was: for rabbit sera 1:10000, mouse sera 1:1000 and
for human sera 1:3000 (reproducible results, without the
Hook effect). Next, the membranes were washed three
times with PBS-T. After washing, the membranes were
incubated for 1 h in alkaline phosphatase-conjugated
goat-anti-rabbit/mouse/human IgG antibodies (Sigma)
diluted 1 : 5000. Finally, the membranes were washed as
six times with PBS-T, and visualized with solution con-
taining nitro blue tetrazolium (NBT, Roth), 5-bromo-4-
chloro-3-indolyl phosphate (BCIP, Roth), and MgCl2
(POCh) for 5 s. Image acquisition (exposure time 1–
4 min) was performed using VersaDoc Imaging System
(Bio-Rad).
Protein identification
After Western blot analysis, the immunoreactive pro-
teins were separated and purified by preparative electro-
phoresis in denaturing condition (SDS-PAGE) using
Prep-Cell apparatus (Model 491 Bio-Rad). Bands of
interest were cut out and digested by trypsin (Roche) to
obtain a mixture of peptides and analyzed by liquid
chromatography (LC), where the mass fragments were
measured using mass spectrometer LC-MS/MS Orbitrap
(Thermo). Peptides were first trapped and desalted on
the enrichment column (Zorbax 300SB-C18, 0.3 ×
5 mm, Agilent) for 5 min (solvent: 2.5 % acetonitrile/
0.5 % formic acid), then separated on a Zorbax 300SB-
C18, 75 μm × 150 mm column (Agilent), using a linear
gradient from 10 to 32 % B (solvent A: 5 % acetonitrile
in water, solvent B: acetonitrile, both with 0.1 % formic
acid). Ions of interest were data-dependently subjected
to MS/MS, according to the expected charge state distri-
bution of peptide ions. Proteins were identified by com-
parative analysis of peptides masses (NCBInr, UniProt,
Bethesda, USA), using MS/MS ion search of the Mascot
search engine (Matrix Science, London, UK, http://
www.matrixscience.com/) and statistical analysis. Only
peptide matches with a score of 1000 or above were ac-
cepted. Immunoreactive properties of separated proteins
were re-tested using immunoblotting.
Serum samples
Thirteen sera were used: four polyclonal rabbit sera,
three mouse sera and six human sera (three of healthy
adult volunteers and three from umbilical cord blood).
Serum was obtained from rabbits immunized with bac-
terial mass of L. paracsei LOCK 0912 (s1), L. animalis
murinus 148 (s2), L. johnsonii 142 (s3) and L. johnsonii
151 (s4) as described before [33]. Briefly, rabbits (5–6
months old) were immunized twice a week with a dried
cell mass suspended in PBS. After the first subcutaneous
injection with 100 μg/ml, the succeeding doubly increas-
ing amounts (200 to 6400 μg/ml) were injected intraven-
ously. After the last injection rabbits were bled, the
separated antisera were decomplemented (56 °C, 30 min)
and stored at −20 °C. Preimmune serum was used as a
control. The experiments were approved by the 1st Local
Committee for Experiments with the Use of Laboratory
Animals, Wroclaw, Poland (number 12/2012). Serum was
obtained from germ free mouse (GF, s5), mouse kept
under specific-pathogen-free conditions (SPF, s6) and
form mouse kept under conventional conditions (CV, s7).
Germ free BALB/c mice were kept under sterile condi-
tions in Trexler-type plastic isolators, exposed to 12:12-h
light-dark cycles and supplied with autoclaved tap water
and 50 kGy irradiated sterile pellet diet Altromin 1410
(Altromin, Lage, Germany) ad libitum. Fecal samples were
weekly controlled for the presence of aerobic and anaer-
obic bacteria, molds and yeast by standard microbiological
methodology. Conventional BALB/c mice were kept in
IVC cages (Tecniplast, Italy), exposed to 12:12-h light-
dark cycles and fed with the same sterile diet as GF coun-
terparts. Animal experiments were approved by the com-
mittee for protection and use of experimental animals of
the Institute of Microbiology. v.v.i., Academy of Sciences
of the Czech Republic. Human adults sera were obtained
from healthy volunteers (s8-s10) and human umbilical
cord sera from healthy women (s11-s13) were obtained
from the Obstetric Clinic of the Medical University of
Wroclaw. Samples were obtained with patients’ written in-
formed consent. The use of umbilical cord sera samples in
this study was approved by the Medical Ethics Committee
of the Medical University of Wroclaw (number KB-882-
2012) and was conducted in accordance with the Helsinki
Declaration of 1975.
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